IRWD - Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A
IEX Last Trade
5.05
-0.060 -1.188%
Share volume: 1,325,722
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.11
-0.06
-1.17%
Summary score
63%
Profitability
98%
Dept financing
31%
Liquidity
31%
Performance
44%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
65.86%
Return on assets
6.65%
Return on sales
48.39%
Return on invested capital
372.18%
Total debt ratio
87.96%
Debt ratio change over timeo
5.76%
Current Ratio
12.94%
Quick Ratio
12.94%
Cash Position Ratio
10.34%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
76.02%
Return on assets
5.92%
Return on sales
27.57%
Return on invested capital
1310.91%
Total debt ratio
166.95%
Debt ratio change over timeo
16.46%
Current Ratio
0.9%
Quick Ratio
0.9%
Cash Position Ratio
0.45%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
1.26%
Return on assets
2.61%
Return on sales
15.3%
Return on invested capital
19.09%
Total debt ratio
175.32%
Debt ratio change over time
60.8%
Current Ratio
0.82%
Quick Ratio
0.82%
Cash Position Ratio
0.48%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
33.06%
Return on assets
-61.06%
Return on sales
175.88%
Return on invested capital
183.69%
Total debt ratio
576.19%
Debt ratio change over time
5.76%
Current Ratio
76.27%
Quick Ratio
76.27%
Cash Position Ratio
60.75%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IRWD | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 65.86% | 13.79% | 34.47% | 7.43% |
| Return on assets | 6.65% | 2.76% | 3.15% | 5.62% |
| Return on sales | 48.39% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 372.18% | 2.36% | 5.39% | 19.77% |
| Profitability | 100% | 31% | 42% | 46% |
| Total debt ratio | 87.96% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | 5.76% | 308.97% | -6.99% | 1.18% |
| Dept financing | 25% | 50% | 25% | 7% |
| Current Ratio | 0.9% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 0.9% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 0.45% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 4% | 9% | 21% |
| Short-term ratios | IRWD | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 76.02% | 13.77% | 13.25% | 3.8% |
| Return on assets | 5.92% | 2.43% | 1.89% | 3.09% |
| Return on sales | 27.57% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 1310.91% | 2.14% | 3.39% | 9.18% |
| Profitability | 98% | 35% | 32% | 39% |
| Total debt ratio | 166.95% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | 16.46% | 46.38% | -72.08% | 1.51% |
| Dept financing | 34% | 39% | 14% | 4% |
| Current Ratio | 0.9% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 0.9% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 0.45% | 0.36% | 1.28% | 2.93% |
| Liquididy | 13% | 12% | 31% | 75% |